The outcome of this project was a mobile application that helped patients get back to their daily lives much quicker. One year after surgery, patients who received nine months of ActaStim-S device therapy were more than twice as likely to achieve overall success versus a placebo control (a study backed by the FDA).
Moreover, two-thirds of the largest US hospitals offer mobile health apps, yet providers pursuing mobile patient engagement fail because apps provide poor user experience and functionality. Data-driven mobile apps that focus on patients first, like ActaStim Sync, have the potential to align functionality with patient needs better. Having just another mobile app is not enough, and it’s time for the medical industry to adopt a more user-centric approach to patient care.
ActaStim-S represents a paradigm shift in patient engagement within the medical landscape. The app's success stems from its meticulous focus on user experience and functionality, addressing the prevalent shortcomings in existing healthcare applications. ActaStim Sync has set a new standard for mobile health apps by leveraging data-driven insights and aligning functionalities with patient needs. The app facilitates effective communication between patients and healthcare providers and empowers individuals to manage their recovery journeys actively.